Recruitment

Recruitment Status
Completed
Estimated Enrollment
60

Inclusion Criteria

patients undergoing major gynecological surgical procedures performed by laparotomy
patients undergoing major abdominal surgical procedures performed by laparotomy
patients undergoing major urological surgical procedures performed by laparotomy
...
patients undergoing major gynecological surgical procedures performed by laparotomy
patients undergoing major abdominal surgical procedures performed by laparotomy
patients undergoing major urological surgical procedures performed by laparotomy
signed informed consent
age ≥ 18 years

Exclusion Criteria

presence of an arterio-venous shunt or of any other vascular disease on upper limb
aortic valve disease
beta blocker treatment, antiarrhythmic treatment, arrhythmia, pace-maker,
...
presence of an arterio-venous shunt or of any other vascular disease on upper limb
aortic valve disease
beta blocker treatment, antiarrhythmic treatment, arrhythmia, pace-maker,
BMI > 35
pregnant women
esophageal disease
allergy to gelatin

Summary

Conditions
Fluid Responsiveness
Type
Interventional
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Supportive Care

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criteria

patients undergoing major gynecological surgical procedures performed by laparotomy
patients undergoing major abdominal surgical procedures performed by laparotomy
patients undergoing major urological surgical procedures performed by laparotomy
...
patients undergoing major gynecological surgical procedures performed by laparotomy
patients undergoing major abdominal surgical procedures performed by laparotomy
patients undergoing major urological surgical procedures performed by laparotomy
signed informed consent
age ≥ 18 years

Exclusion Criteria

presence of an arterio-venous shunt or of any other vascular disease on upper limb
aortic valve disease
beta blocker treatment, antiarrhythmic treatment, arrhythmia, pace-maker,
...
presence of an arterio-venous shunt or of any other vascular disease on upper limb
aortic valve disease
beta blocker treatment, antiarrhythmic treatment, arrhythmia, pace-maker,
BMI > 35
pregnant women
esophageal disease
allergy to gelatin

Tracking Information

NCT #
NCT02040948
Collaborators
Not Provided
Investigators
Not Provided